{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T23:55:57Z","timestamp":1790553357407,"version":"4.1.0"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T00:00:00Z","timestamp":1790467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T00:00:00Z","timestamp":1790467200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100010221","name":"Higher Education Commision, Pakistan","doi-asserted-by":"publisher","award":["No. 20-16428\/NRPU\/R&D\/HEC\/2021"],"award-info":[{"award-number":["No. 20-16428\/NRPU\/R&D\/HEC\/2021"]}],"id":[{"id":"10.13039\/501100010221","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-12793-9","type":"journal-article","created":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T11:07:10Z","timestamp":1790507230000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Anti-phage defense systems in bacteria: molecular mechanisms and their role in shaping phage therapy strategies"],"prefix":"10.1007","volume":"53","author":[{"given":"Shahzar","family":"Khan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Ilyas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aneela","family":"Nawaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Humaira","family":"Nawaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Ismail","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Talha","family":"Bhatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umaar","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samiullah","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,27]]},"reference":[{"key":"12793_CR1","doi-asserted-by":"crossref","unstructured":"Batinovic S et al (2019) Bacteriophages in Natural and Artificial Environments. Pathogens 8(3):100","DOI":"10.3390\/pathogens8030100"},{"key":"12793_CR2","doi-asserted-by":"crossref","unstructured":"Xu X, Gu P (2024) Overview of Phage Defense Systems in Bacteria and Their Applications. Int J Mol Sci 25(24):13316","DOI":"10.3390\/ijms252413316"},{"issue":"1","key":"12793_CR3","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1093\/nar\/gkt990","volume":"42","author":"WAM Loenen","year":"2014","unstructured":"Loenen WAM et al (2014) Highlights of the DNA cutters: a short history of the restriction enzymes. Nucleic Acids Res 42(1):3\u201319","journal-title":"Nucleic Acids Res"},{"key":"12793_CR4","doi-asserted-by":"crossref","unstructured":"Ma J et al (2025) Horizontal acquisition of the Type I restriction\u2013modification system enhances bacterial pathogenicity by mediating methylation of transcription factor-encoding genes. Nucleic Acids Res 53(13):gkaf659","DOI":"10.1093\/nar\/gkaf659"},{"key":"12793_CR5","doi-asserted-by":"crossref","unstructured":"Djordjevic M et al (2025) Nonlinear regulatory dynamics of bacterial restriction-modification systems modulates horizontal gene transfer susceptibility. Nucleic Acids Res 53(2):gkae1322","DOI":"10.1093\/nar\/gkae1322"},{"issue":"6","key":"12793_CR6","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.tibs.2022.02.004","volume":"47","author":"H Lee","year":"2022","unstructured":"Lee H, Sashital DG (2022) Creating memories: molecular mechanisms of CRISPR adaptation. Trends Biochem Sci 47(6):464\u2013476","journal-title":"Trends Biochem Sci"},{"issue":"6","key":"12793_CR7","doi-asserted-by":"publisher","first-page":"2761","DOI":"10.1093\/nar\/gkae167","volume":"52","author":"S Gr\u00fcschow","year":"2024","unstructured":"Gr\u00fcschow S et al (2024) CRISPR antiphage defence mediated by the cyclic nucleotide-binding membrane protein Csx23. Nucleic Acids Res 52(6):2761\u20132775","journal-title":"Nucleic Acids Res"},{"key":"12793_CR8","doi-asserted-by":"publisher","first-page":"100344","DOI":"10.1016\/j.microb.2025.100344","volume":"7","author":"K Saeed","year":"2025","unstructured":"Saeed K et al (2025) CRISPR Cas systems: From bacterial defense mechanisms to revolutionary tools reshaping genetic research and translation therapeutics. Microbe 7:100344","journal-title":"Microbe"},{"issue":"1","key":"12793_CR9","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1146\/annurev-micro-041222-024843","volume":"78","author":"SJ Hobbs","year":"2024","unstructured":"Hobbs SJ, Kranzusch PJ (2024) Nucleotide immune signaling in CBASS, Pycsar, Thoeris, and CRISPR antiphage defense. Annu Rev Microbiol 78(1):255\u2013276","journal-title":"Annu Rev Microbiol"},{"issue":"12","key":"12793_CR10","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1016\/j.tim.2024.05.005","volume":"32","author":"K Murtazalieva","year":"2024","unstructured":"Murtazalieva K et al (2024) The growing repertoire of phage anti-defence systems. Trends Microbiol 32(12):1212\u20131228","journal-title":"Trends Microbiol"},{"issue":"8003","key":"12793_CR11","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/s41586-024-07092-x","volume":"627","author":"G Tamulaitiene","year":"2024","unstructured":"Tamulaitiene G et al (2024) Activation of Thoeris antiviral system via SIR2 effector filament assembly. Nature 627(8003):431\u2013436","journal-title":"Nature"},{"issue":"7987","key":"12793_CR12","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1038\/s41586-023-06612-5","volume":"623","author":"S Camara-Wilpert","year":"2023","unstructured":"Camara-Wilpert S et al (2023) Bacteriophages suppress CRISPR\u2013Cas immunity using RNA-based anti-CRISPRs. Nature 623(7987):601\u2013607","journal-title":"Nature"},{"issue":"12","key":"12793_CR13","doi-asserted-by":"publisher","first-page":"3162","DOI":"10.1038\/s41564-025-02178-2","volume":"10","author":"KA Johnson","year":"2025","unstructured":"Johnson KA et al (2025) A phage-encoded anti-CRISPR protein co-opts host enolase to prevent type III CRISPR immunity. Nat Microbiol 10(12):3162\u20133175","journal-title":"Nat Microbiol"},{"issue":"7","key":"12793_CR14","doi-asserted-by":"publisher","first-page":"911","DOI":"10.3390\/v17070911","volume":"17","author":"C Anastassopoulou","year":"2025","unstructured":"Anastassopoulou C et al (2025) Armed Phages: A New Weapon in the Battle Against Antimicrobial Resistance. Viruses 17(7):911","journal-title":"Viruses"},{"issue":"1","key":"12793_CR15","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/s42003-025-07730-8","volume":"8","author":"W Yamashita","year":"2025","unstructured":"Yamashita W et al (2025) Phage engineering to overcome bacterial Tmn immunity in Dhillonvirus. Commun Biology 8(1):290","journal-title":"Commun Biology"},{"issue":"5","key":"12793_CR16","doi-asserted-by":"publisher","first-page":"330","DOI":"10.52601\/bpr.2025.240070","volume":"11","author":"H Kang","year":"2025","unstructured":"Kang H, Gao A, Zhu Y (2025) Bacterial restriction-modification systems: Mechanisms of defense against phage infection. Biophys Rep 11(5):330","journal-title":"Biophys Rep"},{"issue":"2","key":"12793_CR17","doi-asserted-by":"publisher","first-page":"gkae1322","DOI":"10.1093\/nar\/gkae1322","volume":"53","author":"M Djordjevic","year":"2025","unstructured":"Djordjevic M et al (2025) Nonlinear regulatory dynamics of bacterial restriction-modification systems modulates horizontal gene transfer susceptibility. Nucleic Acids Res 53(2):e1322","journal-title":"Nucleic Acids Res"},{"key":"12793_CR18","doi-asserted-by":"crossref","unstructured":"Qiu Y et al (2025) The restriction impacts of the Type III restriction-modification system on the transmission dynamics of antimicrobial resistance genes in Campylobacter jejuni. Front Microbiol 16:1496275","DOI":"10.3389\/fmicb.2025.1496275"},{"issue":"9","key":"12793_CR19","doi-asserted-by":"publisher","first-page":"4929","DOI":"10.3390\/ijms25094929","volume":"25","author":"M Mart\u00ednez","year":"2024","unstructured":"Mart\u00ednez M, Rizzuto I, Molina R (2024) Knowing Our Enemy in the Antimicrobial Resistance Era: Dissecting the Molecular Basis of Bacterial Defense Systems. Int J Mol Sci 25(9):4929","journal-title":"Int J Mol Sci"},{"issue":"3","key":"12793_CR20","first-page":"52","volume":"13","author":"R Khatun","year":"2025","unstructured":"Khatun R, Sengupta S, Bhattacharya M (2025) Bacterial Microbial Defense Systems: From CRISPR-Cas Mechanisms to Emerging Anti-Phage Strategies. IJoI 13(3):52\u201358","journal-title":"IJoI"},{"issue":"12","key":"12793_CR21","doi-asserted-by":"publisher","first-page":"4748","DOI":"10.1128\/AEM.64.12.4748-4756.1998","volume":"64","author":"E Emond","year":"1998","unstructured":"Emond E et al (1998) AbiQ, an abortive infection mechanism from Lactococcus lactis. Appl Environ Microbiol 64(12):4748\u20134756","journal-title":"Appl Environ Microbiol"},{"issue":"1","key":"12793_CR22","doi-asserted-by":"publisher","first-page":"3141","DOI":"10.1038\/s41467-025-58540-9","volume":"16","author":"H Pu","year":"2025","unstructured":"Pu H et al (2025) A toxin-antitoxin system provides phage defense via DNA damage and repair. Nat Commun 16(1):3141","journal-title":"Nat Commun"},{"key":"12793_CR23","doi-asserted-by":"crossref","unstructured":"Ge Y, Gao A, Zhu Y (2025) Molecular mechanisms of CBASS-mediated bacteriophage defense. Biophysics Reports","DOI":"10.52601\/bpr.2025.250028"},{"issue":"1","key":"12793_CR24","doi-asserted-by":"publisher","first-page":"2604","DOI":"10.1038\/s41467-025-57851-1","volume":"16","author":"Y Cui","year":"2025","unstructured":"Cui Y et al (2025) Bacterial Hachiman complex executes DNA cleavage for antiphage defense. Nat Commun 16(1):2604","journal-title":"Nat Commun"},{"issue":"4","key":"12793_CR25","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.chom.2024.01.015","volume":"32","author":"Y Wu","year":"2024","unstructured":"Wu Y et al (2024) Bacterial defense systems exhibit synergistic anti-phage activity. Cell Host Microbe 32(4):557\u2013572e6","journal-title":"Cell Host Microbe"},{"key":"12793_CR26","doi-asserted-by":"crossref","unstructured":"Shu X et al (2024) CRISPR-Cas supervises diverse anti-phage defense systems. bioRxiv: p. 2024.12. 27.630466","DOI":"10.1101\/2024.12.27.630466"},{"key":"12793_CR27","doi-asserted-by":"crossref","unstructured":"Workman RE et al (2024) Anti-CRISPR proteins trigger a burst of CRISPR-Cas9 expression that enhances phage defense. Cell Rep 43(3):113849","DOI":"10.1016\/j.celrep.2024.113849"},{"issue":"4","key":"12793_CR28","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.chom.2026.02.017","volume":"34","author":"S Yuan","year":"2026","unstructured":"Yuan S et al (2026) Discovery of human gut phage-encoded anti-CRISPR proteins unveils diverse mechanisms for phages to evade type II CRISPR immunity. Cell Host Microbe 34(4):708\u2013719e5","journal-title":"Cell Host Microbe"},{"issue":"1","key":"12793_CR29","doi-asserted-by":"publisher","first-page":"8611","DOI":"10.1038\/s41467-025-63658-x","volume":"16","author":"J Kong","year":"2025","unstructured":"Kong J et al (2025) Molecular mechanisms of CBASS phospholipase effector CapV mediated membrane disruption. Nat Commun 16(1):8611","journal-title":"Nat Commun"},{"issue":"11","key":"12793_CR30","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1038\/s41564-022-01239-0","volume":"7","author":"M Zaremba","year":"2022","unstructured":"Zaremba M et al (2022) Short prokaryotic Argonautes provide defence against incoming mobile genetic elements through NAD+ depletion. Nat Microbiol 7(11):1857\u20131869","journal-title":"Nat Microbiol"},{"issue":"1","key":"12793_CR31","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1038\/s41467-023-44660-7","volume":"15","author":"X Zhen","year":"2024","unstructured":"Zhen X et al (2024) Structural basis of antiphage immunity generated by a prokaryotic Argonaute-associated SPARSA system. Nat Commun 15(1):450","journal-title":"Nat Commun"},{"issue":"1","key":"12793_CR32","doi-asserted-by":"publisher","first-page":"8610","DOI":"10.1038\/s41467-024-52910-5","volume":"15","author":"N Cui","year":"2024","unstructured":"Cui N et al (2024) Tetramerization-dependent activation of the Sir2-associated short prokaryotic Argonaute immune system. Nat Commun 15(1):8610","journal-title":"Nat Commun"},{"issue":"1","key":"12793_CR33","doi-asserted-by":"publisher","first-page":"4852","DOI":"10.1038\/s41467-024-49271-4","volume":"15","author":"J Kottur","year":"2024","unstructured":"Kottur J, Malik R, Aggarwal AK (2024) Nucleic acid mediated activation of a short prokaryotic Argonaute immune system. Nat Commun 15(1):4852","journal-title":"Nat Commun"},{"issue":"4","key":"12793_CR34","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1038\/s41589-023-01478-0","volume":"20","author":"L Guo","year":"2024","unstructured":"Guo L et al (2024) Auto-inhibition and activation of a short Argonaute-associated TIR-APAZ defense system. Nat Chem Biol 20(4):512\u2013520","journal-title":"Nat Chem Biol"},{"issue":"7977","key":"12793_CR35","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1038\/s41586-023-06456-z","volume":"621","author":"Z Shen","year":"2023","unstructured":"Shen Z et al (2023) Oligomerization-mediated activation of a short prokaryotic Argonaute. Nature 621(7977):154\u2013161","journal-title":"Nature"},{"issue":"7935","key":"12793_CR36","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1038\/s41586-022-05375-9","volume":"611","author":"A Leavitt","year":"2022","unstructured":"Leavitt A et al (2022) Viruses inhibit TIR gcADPR signalling to overcome bacterial defence. Nature 611(7935):326\u2013331","journal-title":"Nature"},{"issue":"12","key":"12793_CR37","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1038\/s41422-025-01198-1","volume":"35","author":"E Jurgelaitis","year":"2025","unstructured":"Jurgelaitis E et al (2025) Activation of the SPARDA defense system by filament assembly using a beta-relay signaling mechanism widespread in prokaryotic Argonautes. Cell Res 35(12):1056\u20131078","journal-title":"Cell Res"},{"issue":"7","key":"12793_CR38","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1038\/s41422-025-01100-z","volume":"35","author":"F Wang","year":"2025","unstructured":"Wang F et al (2025) Target DNA-induced filament formation and nuclease activation of SPARDA complex. Cell Res 35(7):510\u2013519","journal-title":"Cell Res"},{"issue":"8","key":"12793_CR39","doi-asserted-by":"publisher","first-page":"e1011831","DOI":"10.1371\/journal.pgen.1011831","volume":"21","author":"M Saunier","year":"2025","unstructured":"Saunier M et al (2025) Deciphering the RNA-based regulation mechanism of the phage-encoded AbiF system in Clostridioides difficile. PLoS Genet 21(8):e1011831","journal-title":"PLoS Genet"},{"issue":"1","key":"12793_CR40","doi-asserted-by":"publisher","first-page":"100254","DOI":"10.1016\/j.engmic.2025.100254","volume":"6","author":"X Tian","year":"2026","unstructured":"Tian X et al (2026) Modulation of Hachiman defence by a type II toxin-antitoxin system via balancing trade-off between the fitness cost and antiphage activity. Eng Microbiol 6(1):100254","journal-title":"Eng Microbiol"},{"issue":"2","key":"12793_CR41","doi-asserted-by":"publisher","first-page":"e03293","DOI":"10.1128\/mbio.03293-23","volume":"15","author":"K Gerdes","year":"2024","unstructured":"Gerdes K (2024) Diverse genetic contexts of HicA toxin domains propose a role in anti-phage defense. mBio 15(2):e03293\u2013e03223","journal-title":"mBio"},{"issue":"1","key":"12793_CR42","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1146\/annurev-virology-100422-125123","volume":"11","author":"LJ Getz","year":"2024","unstructured":"Getz LJ, Maxwell KL (2024) Diverse antiphage defenses are widespread among prophages and mobile genetic elements. Annual Rev Virol 11(1):343\u2013362","journal-title":"Annual Rev Virol"},{"key":"12793_CR43","doi-asserted-by":"crossref","unstructured":"Allemailem KS et al (2024) Current updates of CRISPR\/Cas system and anti-CRISPR proteins: Innovative applications to improve the genome editing strategies. Int J Nanomed 19:10185\u201310212","DOI":"10.2147\/IJN.S479068"},{"issue":"1","key":"12793_CR44","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1186\/s12915-024-02090-x","volume":"22","author":"EV Koonin","year":"2024","unstructured":"Koonin EV, Makarova KS (2024) CRISPR in mobile genetic elements: counter-defense, inter-element competition and RNA-guided transposition. BMC Biol 22(1):295","journal-title":"BMC Biol"},{"key":"12793_CR45","unstructured":"Jungfer K (2024) Molecular Mechanisms of Cyclic Oligoadenylate Signaling During Type III CRISPR-Cas Interference. Universit\u00e4t Z\u00fcrich"},{"issue":"8021","key":"12793_CR46","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1038\/s41586-024-07644-1","volume":"631","author":"N Birkholz","year":"2024","unstructured":"Birkholz N et al (2024) Phage anti-CRISPR control by an RNA- and DNA-binding helix\u2013turn\u2013helix protein. Nature 631(8021):670\u2013677","journal-title":"Nature"},{"issue":"1","key":"12793_CR47","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1038\/s41467-024-45068-7","volume":"15","author":"N Duan","year":"2024","unstructured":"Duan N et al (2024) Structure-guided discovery of anti-CRISPR and anti-phage defense proteins. Nat Commun 15(1):649","journal-title":"Nat Commun"},{"key":"12793_CR48","doi-asserted-by":"crossref","unstructured":"Garb J et al (2026) Synthetically designed anti-defense proteins overcome barriers to bacterial transformation and phage infection. Nat Commun 17:7372","DOI":"10.1038\/s41467-026-74301-8"},{"issue":"9","key":"12793_CR49","doi-asserted-by":"publisher","first-page":"001895","DOI":"10.1099\/jmm.0.001895","volume":"73","author":"CF Uchechukwu","year":"2024","unstructured":"Uchechukwu CF, Shonekan A (2024) Current status of clinical trials for phage therapy. J Med Microbiol 73(9):001895","journal-title":"J Med Microbiol"},{"issue":"6","key":"12793_CR50","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1038\/s41564-024-01705-x","volume":"9","author":"J-P Pirnay","year":"2024","unstructured":"Pirnay J-P et al (2024) Personalized bacteriophage therapy outcomes for 100 consecutive cases: a multicentre, multinational, retrospective observational study. Nat Microbiol 9(6):1434\u20131453","journal-title":"Nat Microbiol"},{"issue":"1","key":"12793_CR51","doi-asserted-by":"publisher","first-page":"2468114","DOI":"10.1080\/20565623.2025.2468114","volume":"11","author":"R Ibrahim","year":"2025","unstructured":"Ibrahim R et al (2025) Unveiling the potential bacteriophage therapy: a systematic review. Future Sci OA 11(1):2468114","journal-title":"Future Sci OA"},{"issue":"1","key":"12793_CR52","doi-asserted-by":"publisher","first-page":"5579","DOI":"10.1038\/s41467-025-60598-4","volume":"16","author":"I Weiner","year":"2025","unstructured":"Weiner I et al (2025) Phage therapy with nebulized cocktail BX004-A for chronic Pseudomonas aeruginosa infections in cystic fibrosis: a randomized first-in-human trial. Nat Commun 16(1):5579","journal-title":"Nat Commun"},{"issue":"1","key":"12793_CR53","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1146\/annurev-virology-012423-110530","volume":"10","author":"A Orom\u00ed-Bosch","year":"2023","unstructured":"Orom\u00ed-Bosch A, Antani JD, Turner PE (2023) Developing phage therapy that overcomes the evolution of bacterial resistance. Annual Rev Virol 10(1):503\u2013524","journal-title":"Annual Rev Virol"},{"issue":"8","key":"12793_CR54","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.3390\/v17081094","volume":"17","author":"ST Abedon","year":"2025","unstructured":"Abedon ST (2025) Phage therapy: combating evolution of bacterial resistance to phages. Viruses 17(8):1094","journal-title":"Viruses"},{"key":"12793_CR55","doi-asserted-by":"crossref","unstructured":"Altamirano FLG et al (2022) Phage-antibiotic combination is a superior treatment against Acinetobacter baumannii in a preclinical study. EBioMedicine, 80:104045","DOI":"10.1016\/j.ebiom.2022.104045"},{"issue":"5","key":"12793_CR56","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1038\/s41591-019-0437-z","volume":"25","author":"RM Dedrick","year":"2019","unstructured":"Dedrick RM et al (2019) Engineered bacteriophages for treatment of a patient with a disseminated drug-resistant Mycobacterium abscessus. Nat Med 25(5):730\u2013733","journal-title":"Nat Med"},{"key":"12793_CR57","doi-asserted-by":"publisher","first-page":"743192","DOI":"10.1016\/j.aquaculture.2025.743192","volume":"612","author":"K Olymon","year":"2026","unstructured":"Olymon K et al (2026) Fish pathogen armor: A review of antiphage defense systems in bacterial fish pathogens. Aquaculture 612:743192","journal-title":"Aquaculture"},{"key":"12793_CR58","doi-asserted-by":"publisher","first-page":"570572","DOI":"10.3389\/fmed.2020.570572","volume":"7","author":"T Ferry","year":"2020","unstructured":"Ferry T et al (2020) Phage therapy as adjuvant to conservative surgery and antibiotics to salvage patients with relapsing S. aureus prosthetic knee infection. Front Med 7:570572","journal-title":"Front Med"},{"issue":"2","key":"12793_CR59","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1556\/1886.2024.00010","volume":"14","author":"VA Eiselt","year":"2024","unstructured":"Eiselt VA, Bereswill S, Heimesaat MM (2024) Phage therapy in prosthetic joint infections caused by Staphylococcus aureus \u2013 A literature review. Eur J Microbiol Immunol 14(2):75\u201385","journal-title":"Eur J Microbiol Immunol"},{"key":"12793_CR60","doi-asserted-by":"publisher","first-page":"1713471","DOI":"10.3389\/fphar.2025.1713471","volume":"16","author":"A Fukaya-Shiba","year":"2025","unstructured":"Fukaya-Shiba A et al (2025) Regulatory considerations for developing phage therapy medicinal products for the treatment of antimicrobial resistant bacterial infections. Front Pharmacol 16:1713471","journal-title":"Front Pharmacol"},{"issue":"1","key":"12793_CR61","doi-asserted-by":"publisher","first-page":"2481178","DOI":"10.1080\/19490976.2025.2481178","volume":"17","author":"E Kurilovich","year":"2025","unstructured":"Kurilovich E, Geva-Zatorsky N (2025) Effects of bacteriophages on gut microbiome functionality. Gut Microbes 17(1):2481178","journal-title":"Gut Microbes"},{"key":"12793_CR62","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.3389\/fmicb.2020.01161","volume":"11","author":"L Bretaudeau","year":"2020","unstructured":"Bretaudeau L et al (2020) Good manufacturing practice (GMP) compliance for phage therapy medicinal products. Front Microbiol 11:1161","journal-title":"Front Microbiol"},{"key":"12793_CR63","doi-asserted-by":"publisher","first-page":"1631359","DOI":"10.3389\/fcimb.2025.1631359","volume":"15","author":"M Fuerst-Wilmes","year":"2025","unstructured":"Fuerst-Wilmes M et al (2025) Regulation of phage therapy medicinal products: developments, challenges, and opportunities. Front Cell Infect Microbiol 15:1631359","journal-title":"Front Cell Infect Microbiol"},{"issue":"12","key":"12793_CR64","doi-asserted-by":"publisher","first-page":"e01418","DOI":"10.1128\/mbio.01418-25","volume":"16","author":"HT Le","year":"2025","unstructured":"Le HT et al (2025) mGem: Immune recognition and clearance of bacteriophages\u2014implications for phage therapy. mBio 16(12):e01418\u2013e01425","journal-title":"mBio"},{"issue":"5","key":"12793_CR65","doi-asserted-by":"publisher","first-page":"e1094","DOI":"10.1093\/infdis\/jiag096","volume":"233","author":"K Bosco","year":"2026","unstructured":"Bosco K et al (2026) Immune Responses to Phage Therapy in Humans: A Review. J Infect Dis 233(5):e1094\u2013e1103","journal-title":"J Infect Dis"},{"issue":"10","key":"12793_CR66","doi-asserted-by":"publisher","first-page":"e714","DOI":"10.1002\/mco2.714","volume":"5","author":"R Wang","year":"2024","unstructured":"Wang R et al (2024) The interaction of innate immune and adaptive immune system. MedComm (2020) 5(10):e714","journal-title":"MedComm (2020)"},{"issue":"1","key":"12793_CR67","doi-asserted-by":"publisher","first-page":"2993","DOI":"10.1038\/s41467-024-47192-w","volume":"15","author":"JD Berkson","year":"2024","unstructured":"Berkson JD et al (2024) Phage-specific immunity impairs efficacy of bacteriophage targeting Vancomycin Resistant Enterococcus in a murine model. Nat Commun 15(1):2993","journal-title":"Nat Commun"},{"issue":"1","key":"12793_CR68","doi-asserted-by":"publisher","first-page":"100168","DOI":"10.1016\/j.imj.2025.100168","volume":"4","author":"O Faruk","year":"2025","unstructured":"Faruk O et al (2025) Phage treatment of multidrug-resistant bacterial infections in humans, animals, and plants: The current status and future prospects. Infect Med 4(1):100168","journal-title":"Infect Med"},{"key":"12793_CR69","unstructured":"Kharrat L (2024) The Immunogenic Signatures in Bacteriophage Genomes and the Human Virome. San Diego State University"},{"key":"12793_CR70","doi-asserted-by":"crossref","unstructured":"Kharrat L et al (2025) Large-Scale Genomic Analysis of CpG-Mediated Immunogenicity in Bacteriophages and a Novel Predictive Risk Index.","DOI":"10.1101\/2025.05.15.652987"},{"issue":"2","key":"12793_CR71","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1021\/acsnano.8b06395","volume":"13","author":"H Peng","year":"2019","unstructured":"Peng H, Chen IA (2019) Rapid colorimetric detection of bacterial species through the capture of gold nanoparticles by chimeric phages. ACS Nano 13(2):1244\u20131252","journal-title":"ACS Nano"},{"issue":"5","key":"12793_CR72","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1021\/acssensors.0c00654","volume":"5","author":"H Peng","year":"2020","unstructured":"Peng H et al (2020) Chimeric phage nanoparticles for rapid characterization of bacterial pathogens: detection in complex biological samples and determination of antibiotic sensitivity. ACS Sens 5(5):1491","journal-title":"ACS Sens"},{"issue":"4","key":"12793_CR73","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1073\/pnas.1913234117","volume":"117","author":"H Peng","year":"2020","unstructured":"Peng H et al (2020) Controlled phage therapy by photothermal ablation of specific bacterial species using gold nanorods targeted by chimeric phages. Proc Natl Acad Sci 117(4):1951\u20131961","journal-title":"Proc Natl Acad Sci"},{"issue":"6","key":"12793_CR74","doi-asserted-by":"publisher","first-page":"3297","DOI":"10.1021\/acsbiomaterials.4c02190","volume":"11","author":"H Peng","year":"2025","unstructured":"Peng H et al (2025) Real-Time in Vivo Bacterial Imaging by Computed Tomography and Fluorescence Using Phage-Gold Nanorod Bioconjugates as Contrast Agents. ACS Biomaterials Sci Eng 11(6):3297","journal-title":"ACS Biomaterials Sci Eng"},{"issue":"3","key":"12793_CR75","doi-asserted-by":"publisher","first-page":"4756","DOI":"10.1021\/acsnano.2c00048","volume":"16","author":"H Peng","year":"2022","unstructured":"Peng H et al (2022) Treatment of wound infections in a mouse model using Zn2+-releasing phage bound to gold nanorods. ACS Nano 16(3):4756","journal-title":"ACS Nano"},{"issue":"6","key":"12793_CR76","doi-asserted-by":"publisher","first-page":"3228","DOI":"10.1021\/acsbiomaterials.5c00218","volume":"11","author":"B Lyu","year":"2025","unstructured":"Lyu B et al (2025) Empowering healthcare with phage display technology. ACS Biomaterials Sci Eng 11(6):3228\u20133248","journal-title":"ACS Biomaterials Sci Eng"},{"key":"12793_CR77","doi-asserted-by":"crossref","unstructured":"Khan S et al (2025) Bacteriophage-based vaccination platform for antigen discovery and development of next-generation vaccines. Next Res, 2: p. 100776","DOI":"10.1016\/j.nexres.2025.100776"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12793-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12793-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12793-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T23:02:00Z","timestamp":1790550120000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-12793-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,27]]},"references-count":77,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["12793"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-12793-9","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,27]]},"assertion":[{"value":"23 August 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1647"}}